| 0 |
BLOOD HUMAN CHORIONIC GONADOTROPIN NEGATIVE |
1 |
0.5000 |
| 1 |
ULTRASOUND SCAN VAGINA ABNORMAL |
1 |
0.1429 |
| 2 |
OPTIC NERVE SHEATH MENINGIOMA |
3 |
0.1364 |
| 3 |
ASSISTED FERTILISATION |
1 |
0.1250 |
| 4 |
POOR RESPONSE TO OVULATION INDUCTION |
1 |
0.0909 |
| 5 |
OVULATION INDUCTION |
1 |
0.0769 |
| 6 |
OVARIAN HYPERSTIMULATION SYNDROME |
43 |
0.0184 |
| 7 |
FAILED IN VITRO FERTILISATION |
1 |
0.0164 |
| 8 |
NIPPLE ENLARGEMENT |
1 |
0.0161 |
| 9 |
ECTOPIC PREGNANCY TERMINATION |
1 |
0.0159 |
| 10 |
OVARIAN NECROSIS |
1 |
0.0159 |
| 11 |
PREMATURE OVULATION |
1 |
0.0128 |
| 12 |
OVARIAN TORSION |
1 |
0.0120 |
| 13 |
BLOOD VISCOSITY ABNORMAL |
1 |
0.0105 |
| 14 |
UTERINE HYPERSTIMULATION |
1 |
0.0098 |
| 15 |
BIOCHEMICAL PREGNANCY |
1 |
0.0093 |
| 16 |
POOR QUALITY DEVICE USED |
91 |
0.0091 |
| 17 |
PROGESTERONE INCREASED |
1 |
0.0090 |
| 18 |
BLOOD LUTEINISING HORMONE INCREASED |
2 |
0.0081 |
| 19 |
APPLICATION SITE NODULE |
1 |
0.0073 |
| 20 |
VACTERL SYNDROME |
1 |
0.0071 |
| 21 |
CONGENITAL CHOROID PLEXUS CYST |
2 |
0.0066 |
| 22 |
TINEA VERSICOLOUR |
2 |
0.0056 |
| 23 |
IN VITRO FERTILISATION |
1 |
0.0055 |
| 24 |
OVARIAN DISORDER |
5 |
0.0053 |
| 25 |
INJECTION SITE ECZEMA |
1 |
0.0052 |
| 26 |
ANOVULATORY CYCLE |
1 |
0.0048 |
| 27 |
BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED |
1 |
0.0047 |
| 28 |
ARNOLD-CHIARI MALFORMATION |
4 |
0.0042 |
| 29 |
PELVIC ADHESIONS |
1 |
0.0042 |
| 30 |
TUBO-OVARIAN ABSCESS |
1 |
0.0041 |
| 31 |
EXPOSURE TO CONTAMINATED DEVICE |
1 |
0.0038 |
| 32 |
HAEMORRHAGIC OVARIAN CYST |
2 |
0.0035 |
| 33 |
NIPPLE DISORDER |
2 |
0.0032 |
| 34 |
PROGESTERONE DECREASED |
1 |
0.0032 |
| 35 |
PROTEIN DEFICIENCY |
1 |
0.0032 |
| 36 |
SALPINGITIS |
1 |
0.0031 |
| 37 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
21 |
0.0031 |
| 38 |
ENTEROBACTER SEPSIS |
1 |
0.0027 |
| 39 |
OVARIAN ENLARGEMENT |
1 |
0.0026 |
| 40 |
RUPTURED ECTOPIC PREGNANCY |
2 |
0.0026 |
| 41 |
LIPOEDEMA |
1 |
0.0025 |
| 42 |
ENDOMETRIAL HYPERTROPHY |
1 |
0.0025 |
| 43 |
GASTROINTESTINAL ANGIODYSPLASIA |
1 |
0.0024 |
| 44 |
TWIN PREGNANCY |
2 |
0.0024 |
| 45 |
THREATENED LABOUR |
1 |
0.0023 |
| 46 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
2 |
0.0022 |
| 47 |
PREGNANCY TEST FALSE POSITIVE |
1 |
0.0021 |
| 48 |
DRAINAGE |
1 |
0.0020 |
| 49 |
ABORTION THREATENED |
1 |
0.0020 |
| 50 |
DRUG EXPOSURE BEFORE PREGNANCY |
2 |
0.0020 |
| 51 |
ECTOPIC PREGNANCY |
6 |
0.0019 |
| 52 |
SPINA BIFIDA |
4 |
0.0019 |
| 53 |
DEVICE USE CONFUSION |
1 |
0.0019 |
| 54 |
OVARIAN FAILURE |
1 |
0.0019 |
| 55 |
MORNING SICKNESS |
1 |
0.0018 |
| 56 |
ANENCEPHALY |
1 |
0.0018 |
| 57 |
BREAST DISCHARGE |
3 |
0.0017 |
| 58 |
BLOOD OESTROGEN INCREASED |
1 |
0.0017 |
| 59 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
4 |
0.0017 |
| 60 |
HYPERCOAGULATION |
3 |
0.0016 |
| 61 |
GASTROINTESTINAL MUCOSAL DISORDER |
1 |
0.0015 |
| 62 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
51 |
0.0015 |
| 63 |
LEIOMYOMA |
1 |
0.0014 |
| 64 |
POOR QUALITY PRODUCT ADMINISTERED |
15 |
0.0014 |
| 65 |
PELVIC FLUID COLLECTION |
1 |
0.0014 |
| 66 |
HEMIANOPIA HOMONYMOUS |
1 |
0.0014 |
| 67 |
PRODUCT LEAKAGE |
7 |
0.0012 |
| 68 |
SEPSIS NEONATAL |
1 |
0.0012 |
| 69 |
VULVOVAGINAL ERYTHEMA |
1 |
0.0012 |
| 70 |
CAROTID ARTERY THROMBOSIS |
1 |
0.0012 |
| 71 |
INTENTIONAL DEVICE USE ISSUE |
1 |
0.0012 |
| 72 |
CHOROIDAL NEOVASCULARISATION |
1 |
0.0012 |
| 73 |
ABSCESS DRAINAGE |
1 |
0.0012 |
| 74 |
ADVERSE FOOD REACTION |
1 |
0.0011 |
| 75 |
PELVIC DISCOMFORT |
1 |
0.0011 |
| 76 |
EXPOSURE VIA DIRECT CONTACT |
1 |
0.0011 |
| 77 |
MESENTERIC VEIN THROMBOSIS |
1 |
0.0010 |
| 78 |
NIPPLE PAIN |
2 |
0.0010 |
| 79 |
NO ADVERSE EVENT |
176 |
0.0010 |
| 80 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
0.0009 |
| 81 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
23 |
0.0009 |
| 82 |
DEVICE DISPENSING ERROR |
1 |
0.0008 |
| 83 |
PRODUCT PACKAGING ISSUE |
8 |
0.0008 |
| 84 |
VAGINAL ODOUR |
1 |
0.0008 |
| 85 |
PRODUCT CONTAMINATION PHYSICAL |
2 |
0.0008 |
| 86 |
ADNEXA UTERI PAIN |
1 |
0.0008 |
| 87 |
OVARIAN CYST RUPTURED |
1 |
0.0008 |
| 88 |
CALCIUM DEFICIENCY |
1 |
0.0008 |
| 89 |
ABDOMINAL DISTENSION |
80 |
0.0008 |
| 90 |
BREAST SWELLING |
2 |
0.0007 |
| 91 |
PRODUCT DELIVERY MECHANISM ISSUE |
4 |
0.0007 |
| 92 |
EFFUSION |
1 |
0.0007 |
| 93 |
INJECTION SITE HYPOAESTHESIA |
1 |
0.0007 |
| 94 |
HAEMORRHAGIC TRANSFORMATION STROKE |
1 |
0.0007 |
| 95 |
ADHESION |
1 |
0.0007 |
| 96 |
RUBBER SENSITIVITY |
1 |
0.0007 |
| 97 |
POLYCYSTIC OVARIES |
1 |
0.0006 |
| 98 |
INFERTILITY FEMALE |
1 |
0.0006 |
| 99 |
INJECTION SITE HYPERSENSITIVITY |
2 |
0.0006 |
| 100 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 101 |
DEVICE DEFECTIVE |
11 |
0.0006 |
| 102 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
1 |
0.0006 |
| 103 |
DEVICE MALFUNCTION |
43 |
0.0006 |
| 104 |
EXPIRED DEVICE USED |
2 |
0.0006 |
| 105 |
DEVICE LEAKAGE |
26 |
0.0006 |
| 106 |
SLEEP TALKING |
1 |
0.0006 |
| 107 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 108 |
PRODUCT TAMPERING |
1 |
0.0006 |
| 109 |
NEEDLE ISSUE |
16 |
0.0005 |
| 110 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 111 |
BREAST TENDERNESS |
4 |
0.0005 |
| 112 |
PRODUCT QUALITY ISSUE |
69 |
0.0005 |
| 113 |
DEVICE MATERIAL ISSUE |
1 |
0.0005 |
| 114 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 115 |
EAR SWELLING |
1 |
0.0005 |
| 116 |
INJECTION SITE IRRITATION |
6 |
0.0005 |
| 117 |
ANAEMIA MACROCYTIC |
1 |
0.0005 |
| 118 |
PRODUCT DISPENSING ISSUE |
2 |
0.0005 |
| 119 |
VULVOVAGINAL DISCOMFORT |
2 |
0.0005 |
| 120 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 121 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 122 |
ABORTION SPONTANEOUS |
17 |
0.0004 |
| 123 |
INJECTION SITE REACTION |
29 |
0.0004 |
| 124 |
ENDOMETRIOSIS |
2 |
0.0004 |
| 125 |
LIQUID PRODUCT PHYSICAL ISSUE |
3 |
0.0004 |
| 126 |
EYE OEDEMA |
1 |
0.0004 |
| 127 |
EXPIRED DRUG ADMINISTERED |
2 |
0.0004 |
| 128 |
INJECTION SITE ABSCESS |
1 |
0.0004 |
| 129 |
LACTOSE INTOLERANCE |
1 |
0.0004 |
| 130 |
EAR CONGESTION |
1 |
0.0004 |
| 131 |
NORMAL NEWBORN |
2 |
0.0004 |
| 132 |
LIP BLISTER |
1 |
0.0004 |
| 133 |
THYROID NEOPLASM |
1 |
0.0004 |
| 134 |
MENSTRUAL DISORDER |
3 |
0.0004 |
| 135 |
MATERNAL EXPOSURE DURING PREGNANCY |
32 |
0.0004 |
| 136 |
INJECTION SITE RASH |
11 |
0.0004 |
| 137 |
INJECTION SITE PRURITUS |
24 |
0.0004 |
| 138 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 139 |
HOT FLUSH |
26 |
0.0003 |
| 140 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 141 |
INJECTION SITE BRUISING |
27 |
0.0003 |
| 142 |
EMERGENCY CARE |
1 |
0.0003 |
| 143 |
FOETAL GROWTH RESTRICTION |
2 |
0.0003 |
| 144 |
DEVICE BREAKAGE |
13 |
0.0003 |
| 145 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
2 |
0.0003 |
| 146 |
LOOSE TOOTH |
1 |
0.0003 |
| 147 |
POLYP |
2 |
0.0003 |
| 148 |
OVARIAN CYST |
3 |
0.0003 |
| 149 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 150 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 151 |
INCORRECT DOSE ADMINISTERED |
67 |
0.0003 |
| 152 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 153 |
INJECTION SITE DISCOMFORT |
3 |
0.0003 |
| 154 |
BREAST PAIN |
3 |
0.0003 |
| 155 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 156 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 157 |
HYPERTHYROIDISM |
4 |
0.0003 |
| 158 |
UTERINE LEIOMYOMA |
2 |
0.0003 |
| 159 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 160 |
INJECTION SITE MASS |
10 |
0.0003 |
| 161 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 162 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 163 |
MATERNAL DRUGS AFFECTING FOETUS |
2 |
0.0003 |
| 164 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0003 |
| 165 |
MOOD SWINGS |
8 |
0.0003 |
| 166 |
MUSCLE HAEMORRHAGE |
1 |
0.0002 |
| 167 |
CYST |
3 |
0.0002 |
| 168 |
PRODUCT STORAGE ERROR |
21 |
0.0002 |
| 169 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
11 |
0.0002 |
| 170 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 171 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 172 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 173 |
DEVICE OPERATIONAL ISSUE |
1 |
0.0002 |
| 174 |
CHAPPED LIPS |
1 |
0.0002 |
| 175 |
PRODUCT PRESCRIBING ISSUE |
5 |
0.0002 |
| 176 |
ADVERSE REACTION |
3 |
0.0002 |
| 177 |
PRODUCT AVAILABILITY ISSUE |
5 |
0.0002 |
| 178 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 179 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 180 |
INJECTION SITE ERYTHEMA |
27 |
0.0002 |
| 181 |
PRODUCT DOSE OMISSION |
14 |
0.0002 |
| 182 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 183 |
EXPOSURE DURING PREGNANCY |
13 |
0.0002 |
| 184 |
VAGINAL HAEMORRHAGE |
9 |
0.0002 |
| 185 |
STILLBIRTH |
1 |
0.0002 |
| 186 |
INJECTION SITE PAIN |
63 |
0.0002 |
| 187 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 188 |
INJECTION SITE URTICARIA |
5 |
0.0002 |
| 189 |
SMALL FOR DATES BABY |
1 |
0.0002 |
| 190 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 191 |
PREGNANCY |
4 |
0.0002 |
| 192 |
VAGINAL DISCHARGE |
2 |
0.0002 |
| 193 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 194 |
THYROID DISORDER |
3 |
0.0002 |
| 195 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 196 |
EXPOSURE VIA SKIN CONTACT |
5 |
0.0002 |
| 197 |
HEADACHE |
120 |
0.0002 |
| 198 |
CHEILITIS |
1 |
0.0002 |
| 199 |
PRODUCT DOSE OMISSION ISSUE |
54 |
0.0002 |
| 200 |
MOOD ALTERED |
5 |
0.0002 |
| 201 |
DEVICE DIFFICULT TO USE |
12 |
0.0002 |
| 202 |
NECROSIS |
1 |
0.0002 |
| 203 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 204 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
3 |
0.0002 |
| 205 |
CAESAREAN SECTION |
2 |
0.0002 |
| 206 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 207 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 208 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 209 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 210 |
BLEPHAROSPASM |
1 |
0.0002 |
| 211 |
THERAPEUTIC RESPONSE CHANGED |
1 |
0.0002 |
| 212 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 213 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
1 |
0.0002 |
| 214 |
BRADYPHRENIA |
1 |
0.0002 |
| 215 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 216 |
LIP SWELLING |
5 |
0.0001 |
| 217 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 218 |
INJURY ASSOCIATED WITH DEVICE |
3 |
0.0001 |
| 219 |
DEVICE ISSUE |
13 |
0.0001 |
| 220 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 221 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 222 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 223 |
PEMPHIGOID |
1 |
0.0001 |
| 224 |
APPLICATION SITE PRURITUS |
3 |
0.0001 |
| 225 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 226 |
EMOTIONAL DISORDER |
4 |
0.0001 |
| 227 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 228 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 229 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 230 |
BLOOD DISORDER |
1 |
0.0001 |
| 231 |
CONTUSION |
12 |
0.0001 |
| 232 |
MUSCLE DISORDER |
1 |
0.0001 |
| 233 |
EMBOLISM |
1 |
0.0001 |
| 234 |
INJECTION SITE SWELLING |
9 |
0.0001 |
| 235 |
MIGRAINE |
11 |
0.0001 |
| 236 |
DEVICE USE ISSUE |
2 |
0.0001 |
| 237 |
NAIL DISORDER |
1 |
0.0001 |
| 238 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 239 |
HAEMARTHROSIS |
1 |
0.0001 |
| 240 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 241 |
LIP DRY |
1 |
0.0001 |
| 242 |
HIDRADENITIS |
1 |
0.0001 |
| 243 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
0.0001 |
| 244 |
ADVERSE EVENT |
10 |
0.0001 |
| 245 |
LEUKAEMIA |
1 |
0.0001 |
| 246 |
PRODUCT DOSE OMISSION IN ERROR |
3 |
0.0001 |
| 247 |
URTICARIA |
17 |
0.0001 |
| 248 |
EAR DISCOMFORT |
1 |
0.0001 |
| 249 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 250 |
TENDERNESS |
1 |
0.0001 |
| 251 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 252 |
MUSCLE SPASMS |
17 |
0.0001 |
| 253 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 254 |
OESOPHAGITIS |
1 |
0.0001 |
| 255 |
SCAB |
1 |
0.0001 |
| 256 |
ACCIDENTAL EXPOSURE TO PRODUCT |
9 |
0.0001 |
| 257 |
FATIGUE |
67 |
0.0001 |
| 258 |
BURNING SENSATION |
6 |
0.0001 |
| 259 |
SWELLING |
8 |
0.0001 |
| 260 |
DRUG DOSE OMISSION |
14 |
0.0001 |
| 261 |
CHOLECYSTITIS |
1 |
0.0001 |
| 262 |
IRRITABILITY |
5 |
0.0001 |
| 263 |
CRYING |
3 |
0.0001 |
| 264 |
ACCIDENTAL OVERDOSE |
3 |
0.0001 |
| 265 |
PRURITUS |
31 |
0.0001 |
| 266 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 267 |
DEVICE DEPLOYMENT ISSUE |
1 |
0.0001 |
| 268 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 269 |
CONSTIPATION |
17 |
0.0001 |
| 270 |
HIATUS HERNIA |
1 |
0.0001 |
| 271 |
NAUSEA |
61 |
0.0001 |
| 272 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 273 |
NODULE |
1 |
0.0001 |
| 274 |
APPLICATION SITE ERYTHEMA |
2 |
0.0001 |
| 275 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 276 |
GASTRITIS |
2 |
0.0001 |
| 277 |
DYSMENORRHOEA |
1 |
0.0001 |
| 278 |
FEAR |
2 |
0.0001 |
| 279 |
SINUS CONGESTION |
1 |
0.0001 |
| 280 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 281 |
FOETAL EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 282 |
LIMB INJURY |
2 |
0.0001 |
| 283 |
RASH |
32 |
0.0001 |
| 284 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 285 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 286 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 287 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 288 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 289 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 290 |
ASCITES |
2 |
0.0001 |
| 291 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 292 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 293 |
DISCOMFORT |
4 |
0.0001 |
| 294 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 295 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 296 |
BRAIN FOG |
1 |
0.0001 |
| 297 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 298 |
PNEUMOTHORAX |
1 |
0.0001 |
| 299 |
NIGHT SWEATS |
2 |
0.0001 |
| 300 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 301 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 302 |
CHOLELITHIASIS |
2 |
0.0001 |
| 303 |
FUNGAL INFECTION |
2 |
0.0001 |
| 304 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 305 |
ANGER |
2 |
0.0001 |
| 306 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 307 |
METRORRHAGIA |
1 |
0.0001 |
| 308 |
THERAPY CESSATION |
3 |
0.0001 |
| 309 |
SCAR |
1 |
0.0001 |
| 310 |
PARANOIA |
1 |
0.0001 |
| 311 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 312 |
SYRINGE ISSUE |
1 |
0.0001 |
| 313 |
PRODUCT USE IN UNAPPROVED INDICATION |
14 |
0.0001 |
| 314 |
TACHYCARDIA |
5 |
0.0001 |
| 315 |
THIRST |
1 |
0.0001 |
| 316 |
RASH PRURITIC |
3 |
0.0001 |
| 317 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 318 |
BONE DISORDER |
1 |
0.0001 |
| 319 |
UNDERDOSE |
4 |
0.0001 |
| 320 |
ABDOMINAL DISCOMFORT |
9 |
0.0001 |
| 321 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 322 |
FEELING JITTERY |
1 |
0.0001 |
| 323 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 324 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 325 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 326 |
EAR PAIN |
1 |
0.0001 |
| 327 |
ORAL HERPES |
1 |
0.0001 |
| 328 |
DRUG DOSE OMISSION BY DEVICE |
4 |
0.0001 |
| 329 |
MENORRHAGIA |
1 |
0.0001 |
| 330 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 331 |
WEIGHT INCREASED |
11 |
0.0000 |
| 332 |
FEELING HOT |
3 |
0.0000 |
| 333 |
DIZZINESS |
24 |
0.0000 |
| 334 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 335 |
HYPOACUSIS |
2 |
0.0000 |
| 336 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 337 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 338 |
SWELLING FACE |
3 |
0.0000 |
| 339 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 340 |
RASH PAPULAR |
1 |
0.0000 |
| 341 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
9 |
0.0000 |
| 342 |
ABDOMINAL PAIN UPPER |
9 |
0.0000 |
| 343 |
SKIN IRRITATION |
2 |
0.0000 |
| 344 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 345 |
LOCALISED INFECTION |
1 |
0.0000 |
| 346 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 347 |
LIVER INJURY |
1 |
0.0000 |
| 348 |
VOMITING |
19 |
0.0000 |
| 349 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 350 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 351 |
FLUID RETENTION |
2 |
0.0000 |
| 352 |
ABDOMINAL PAIN |
9 |
0.0000 |
| 353 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 354 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 355 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 356 |
PAIN |
23 |
0.0000 |
| 357 |
THROMBOSIS |
3 |
0.0000 |
| 358 |
PAIN OF SKIN |
1 |
0.0000 |
| 359 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 360 |
PALLOR |
1 |
0.0000 |
| 361 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 362 |
VISION BLURRED |
5 |
0.0000 |
| 363 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 364 |
NECK PAIN |
2 |
0.0000 |
| 365 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 366 |
PALPITATIONS |
4 |
0.0000 |
| 367 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 368 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 369 |
FEELING ABNORMAL |
8 |
0.0000 |
| 370 |
PREMATURE BABY |
1 |
0.0000 |
| 371 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 372 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 373 |
PERIPHERAL SWELLING |
5 |
0.0000 |
| 374 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 375 |
PRODUCT USE ISSUE |
6 |
0.0000 |
| 376 |
PARAESTHESIA |
5 |
0.0000 |
| 377 |
DRUG INTERACTION |
5 |
0.0000 |
| 378 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 379 |
DYSPEPSIA |
3 |
0.0000 |
| 380 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 381 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 382 |
SKIN DISORDER |
1 |
0.0000 |
| 383 |
GAIT INABILITY |
1 |
0.0000 |
| 384 |
SOMNOLENCE |
6 |
0.0000 |
| 385 |
EYE PRURITUS |
1 |
0.0000 |
| 386 |
FLUSHING |
3 |
0.0000 |
| 387 |
DIARRHOEA |
19 |
0.0000 |
| 388 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 389 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 390 |
ERYTHEMA |
6 |
0.0000 |
| 391 |
RASH MACULAR |
1 |
0.0000 |
| 392 |
COVID-19 |
5 |
0.0000 |
| 393 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 394 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 395 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 396 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 397 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 398 |
DYSURIA |
1 |
0.0000 |
| 399 |
CHEST PAIN |
5 |
0.0000 |
| 400 |
EYE SWELLING |
1 |
0.0000 |
| 401 |
HYPOAESTHESIA |
4 |
0.0000 |
| 402 |
ACNE |
2 |
0.0000 |
| 403 |
CHILLS |
3 |
0.0000 |
| 404 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 405 |
POLLAKIURIA |
1 |
0.0000 |
| 406 |
DRY SKIN |
3 |
0.0000 |
| 407 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 408 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 409 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 410 |
CARDIAC DISORDER |
2 |
0.0000 |
| 411 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 412 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 413 |
HEART RATE INCREASED |
2 |
0.0000 |
| 414 |
DRY EYE |
1 |
0.0000 |
| 415 |
SYNCOPE |
2 |
0.0000 |
| 416 |
SINUSITIS |
2 |
0.0000 |
| 417 |
DYSPNOEA |
11 |
0.0000 |
| 418 |
INFLAMMATION |
1 |
0.0000 |
| 419 |
NERVOUSNESS |
1 |
0.0000 |
| 420 |
ECZEMA |
1 |
0.0000 |
| 421 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 422 |
DRUG INEFFECTIVE |
25 |
0.0000 |
| 423 |
DEPRESSED MOOD |
1 |
0.0000 |
| 424 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 425 |
INSOMNIA |
5 |
0.0000 |
| 426 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 427 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 428 |
MEDICATION ERROR |
1 |
0.0000 |
| 429 |
COUGH |
5 |
0.0000 |
| 430 |
BLISTER |
1 |
0.0000 |
| 431 |
MYALGIA |
3 |
0.0000 |
| 432 |
FLATULENCE |
1 |
0.0000 |
| 433 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 434 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 435 |
ANXIETY |
5 |
0.0000 |
| 436 |
LETHARGY |
1 |
0.0000 |
| 437 |
EYE IRRITATION |
1 |
0.0000 |
| 438 |
PYREXIA |
6 |
0.0000 |
| 439 |
DECREASED APPETITE |
4 |
0.0000 |
| 440 |
SURGERY |
1 |
0.0000 |
| 441 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 442 |
VERTIGO |
1 |
0.0000 |
| 443 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 444 |
RHINORRHOEA |
1 |
0.0000 |
| 445 |
DEVICE EXPULSION |
1 |
0.0000 |
| 446 |
PSORIASIS |
2 |
0.0000 |
| 447 |
ALOPECIA |
3 |
0.0000 |
| 448 |
DEHYDRATION |
2 |
0.0000 |
| 449 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 450 |
INJURY |
1 |
0.0000 |
| 451 |
SLEEP DISORDER |
1 |
0.0000 |
| 452 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 453 |
OVERDOSE |
3 |
0.0000 |
| 454 |
AGITATION |
1 |
0.0000 |
| 455 |
DYSGEUSIA |
1 |
0.0000 |
| 456 |
ASTHENIA |
5 |
0.0000 |
| 457 |
HALLUCINATION |
1 |
0.0000 |
| 458 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 459 |
BACK PAIN |
3 |
0.0000 |
| 460 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 461 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 462 |
TREMOR |
2 |
0.0000 |
| 463 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 464 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 465 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 466 |
MALAISE |
5 |
0.0000 |
| 467 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 468 |
OFF LABEL USE |
9 |
0.0000 |
| 469 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 470 |
ILLNESS |
1 |
0.0000 |
| 471 |
HAEMORRHAGE |
1 |
0.0000 |
| 472 |
FALL |
3 |
0.0000 |
| 473 |
INFLUENZA |
1 |
0.0000 |
| 474 |
ASTHMA |
1 |
0.0000 |
| 475 |
DEPRESSION |
2 |
0.0000 |
| 476 |
SEIZURE |
1 |
0.0000 |
| 477 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 478 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 479 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 480 |
HYPERHIDROSIS |
1 |
0.0000 |
| 481 |
RENAL FAILURE |
1 |
0.0000 |
| 482 |
ARTHRALGIA |
3 |
0.0000 |
| 483 |
HOSPITALISATION |
1 |
0.0000 |
| 484 |
PNEUMONIA |
2 |
0.0000 |
| 485 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 486 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 487 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 488 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 489 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 490 |
HYPOTENSION |
1 |
0.0000 |
| 491 |
HYPERTENSION |
1 |
0.0000 |
| 492 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 493 |
CONDITION AGGRAVATED |
1 |
0.0000 |